Skip to menu Skip to content Skip to footer
Honorary Professor

Janet Hardy

Email: 

Overview

Availability

Honorary Professor Janet Hardy is:
Available for supervision

Qualifications

  • Royal Australasian College of Physicians, Royal Australasian College of Physicians

Works

Search Professor Janet Hardy’s works on UQ eSpace

255 works between 1987 and 2025

1 - 20 of 255 works

2025

Journal Article

Has medicinal cannabis found a role in oncology/palliative care?

Hardy, Janet R. and Good, Phillip (2025). Has medicinal cannabis found a role in oncology/palliative care?. Internal Medicine Journal, 55 (2), 183-185. doi: 10.1111/imj.16632

Has medicinal cannabis found a role in oncology/palliative care?

2024

Journal Article

Orally dissolving pilocarpine tablets for xerostomia in advanced cancer: A pilot N-of-1 feasibility study

Foster, Karyn, Mitchell, Geoff, Richard, Evan, Steadman, Kathryn J., Senior, Hugh, Estafanos, Rose and Hardy, Janet (2024). Orally dissolving pilocarpine tablets for xerostomia in advanced cancer: A pilot N-of-1 feasibility study. Palliative Medicine, 39 (2), 298-306. doi: 10.1177/02692163241306269

Orally dissolving pilocarpine tablets for xerostomia in advanced cancer: A pilot N-of-1 feasibility study

2024

Journal Article

Drug interactions in people on cannabidiol: is there cause for concern?

Downs, Georgia, Greer, Ristan, Moses, Geraldine, Gurgenci, Taylan, Good, Phillip and Hardy, Janet (2024). Drug interactions in people on cannabidiol: is there cause for concern?. Cannabis and Cannabinoid Research. doi: 10.1089/can.2024.0041

Drug interactions in people on cannabidiol: is there cause for concern?

2024

Conference Publication

Clinical studies of medicinal cannabis in palliative care – The development of a research program

Good, Phillip, Foster, Karyn, Greer, Ristan, Pelecanos, Anita, Huggett, Georgie, Kearney, Alison, Gurgenci, Taylan and Hardy, Janet (2024). Clinical studies of medicinal cannabis in palliative care – The development of a research program. ANZSPM 2024 Biennial Conference, Adelaide, SA, United States, 5-8 September 2024. London, United Kingdom: BMJ Group. doi: 10.1136/spcare-2024-anzspm.63

Clinical studies of medicinal cannabis in palliative care – The development of a research program

2024

Conference Publication

A study into the benefit of ‘standard palliative care’ on symptom control in randomised controlled trials

Weerasinghe, Aanjanee Dodanwela, Gurgenci, Taylan, Hardy, Janet and Good, Phillip (2024). A study into the benefit of ‘standard palliative care’ on symptom control in randomised controlled trials. ANZSPM 2024 Biennial Conference, Adelaide, SA Australia, 5 - 8 September 2024. London, United Kingdom: BMJ Group. doi: 10.1136/spcare-2024-anzspm.19

A study into the benefit of ‘standard palliative care’ on symptom control in randomised controlled trials

2024

Conference Publication

A double-blind randomised controlled trial of dose-escalated CBD/THC oil for symptom management in advanced cancer

Good, Phillip, Greer, Ristan, Pelecanos, Anita, Kearney, Alison, Huggett, Georgie, Gurgenci, Taylan and Hardy, Janet (2024). A double-blind randomised controlled trial of dose-escalated CBD/THC oil for symptom management in advanced cancer. ANZSPM 2024 Biennial Conference, Adelaide, SA Australia, 5 - 8 September 2024. London, United Kingdom: BMJ Group. doi: 10.1136/spcare-2024-anzspm.11

A double-blind randomised controlled trial of dose-escalated CBD/THC oil for symptom management in advanced cancer

2024

Conference Publication

Drug interactions in people on cannabidiol – is there cause for concern?

Downs, Georgia, Greer, Ristan, Moses, Geraldine, Gurgenci, Taylan, Good, Phillip and Hardy, Janet (2024). Drug interactions in people on cannabidiol – is there cause for concern?. ANZSPM 2024 Biennial Conference, Adelaide, SA Australia, 5 - 8 September 2024. London, United Kingdom: BMJ Group. doi: 10.1136/spcare-2024-anzspm.62

Drug interactions in people on cannabidiol – is there cause for concern?

2024

Journal Article

Drug dependence epidemiology in palliative care medicinal cannabis trials

Lee, Chee Yen, Good, Phillip, Huggett, Georgie, Greer, Ristan and Hardy, Janet (2024). Drug dependence epidemiology in palliative care medicinal cannabis trials. BMJ Supportive and Palliative Care, 14 (3), 295-298. doi: 10.1136/spcare-2023-004583

Drug dependence epidemiology in palliative care medicinal cannabis trials

2024

Conference Publication

Genomic variation in symptom expression in men with castrate resistant prostate cancer

Good, Phillip, Foster, Karyn, Greer, Ristan, Oliveira, Niara, Vayne-Bossert, Petra, Ewing, Adam and Hardy, Janet (2024). Genomic variation in symptom expression in men with castrate resistant prostate cancer. ANZSPM 2024 Biennial Conference, Adelaide, SA, United States, 5-8 September 2024. London, United Kingdom: BMJ Group. doi: 10.1136/spcare-2024-anzspm.61

Genomic variation in symptom expression in men with castrate resistant prostate cancer

2024

Journal Article

Top Ten Tips Palliative Care Clinicians Should Know About Interpreting a Clinical Trial

Gurgenci, Taylan, O’Leary, Cian, Hui, David, Yennu, Sriram, Bruera, Eduardo, Davis, Mellar, Agar, Meera R., Zimmermann, Camilla, Philip, Jennifer, Mercadante, Sebastiano, Hardy, Janet, Rosa, William E. and Good, Phillip (2024). Top Ten Tips Palliative Care Clinicians Should Know About Interpreting a Clinical Trial. Journal of Palliative Medicine. doi: 10.1089/jpm.2024.0258

Top Ten Tips Palliative Care Clinicians Should Know About Interpreting a Clinical Trial

2024

Book Chapter

Measuring wellbeing: a critical rapid review of scales used in advanced cancer contexts

Smith, Alexandra, Olson, Rebecca, Cuerton, Maddison, Khalil, Keesha Abdul, Good, Phillip and Hardy, Janet (2024). Measuring wellbeing: a critical rapid review of scales used in advanced cancer contexts. Researching contemporary wellness cultures. (pp. 63-79) edited by Naomi Smith, Clare Southerton and Marianne Clark. Leeds, United Kingdom: Emerald Publishing. doi: 10.1108/978-1-80455-584-220241005

Measuring wellbeing: a critical rapid review of scales used in advanced cancer contexts

2024

Journal Article

Psychological distress and physical symptoms in advanced cancer: cross-sectional study

Podbury, Bridget, Gurgenci, Taylan, Huggett, Georgie, Greer, Ristan, Hardy, Janet and Good, Phillip (2024). Psychological distress and physical symptoms in advanced cancer: cross-sectional study. BMJ Supportive and Palliative Care. doi: 10.1136/spcare-2024-004940

Psychological distress and physical symptoms in advanced cancer: cross-sectional study

2024

Conference Publication

A randomized, double-blind controlled trial of medicinal cannabis vs placebo for symptom management in patients with advanced cancer receiving palliative care

Hardy, Janet Rea, Greer, Ristan, Gurgenci, Taylan, Kearney, Alison, Ladwa, Rahul, Huggett, Georgie and Good, Phillip (2024). A randomized, double-blind controlled trial of medicinal cannabis vs placebo for symptom management in patients with advanced cancer receiving palliative care. 2024 ASCO Annual Meeting, Chicago, IL United States, 31 May - 4 June 2024. Alexandria, VA United States: American Society of Clinical Oncology. doi: 10.1200/JCO.2024.42.16_suppl.12020

A randomized, double-blind controlled trial of medicinal cannabis vs placebo for symptom management in patients with advanced cancer receiving palliative care

2024

Journal Article

Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a randomised controlled trial

Gurgenci, Taylan, Hardy, Janet, Huggett, Georgie, Foster, Karyn, Pelecanos, Anita, Greer, Ristan, Philip, Jennifer, Haywood, Alison, Mendis, Ruwani, Yates, Patsy and Good, Phillip (2024). Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a randomised controlled trial. Trials, 25 (1) 293. doi: 10.1186/s13063-024-08091-z

Medicinal Cannabis (MedCan 3): a randomised, multicentre, double-blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer—a study protocol for a randomised controlled trial

2024

Journal Article

Preliminary results from a Phase IV surveillance study of medical cannabis use in Australian patients with advanced cancer receiving palliative care

Gurgenci, Taylan, Hardy, Janet, Good, Christopher and Good, Phillip (2024). Preliminary results from a Phase IV surveillance study of medical cannabis use in Australian patients with advanced cancer receiving palliative care. Journal of Palliative Medicine, 27 (5), 663-666. doi: 10.1089/jpm.2023.0358

Preliminary results from a Phase IV surveillance study of medical cannabis use in Australian patients with advanced cancer receiving palliative care

2024

Journal Article

The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life

Haupt, Larisa M., Haywood, Alison, Sutherland, Heidi G., Yu, Chieh, Albury, Cassie L., Pharasi, Anushka, Zunk, Mathew, George, Rani, Griffiths, Lyn R., Good, Phillip and Hardy, Janet (2024). The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life. Scientific Reports, 14 (1) 3411, 1-9. doi: 10.1038/s41598-024-54009-9

The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life

2024

Journal Article

Cannabinol oil or placebo in advanced cancer–disease progression and survival: a secondary analysis

O’Leary, Cian, Greer, Ristan, Huggett, Georgie, Good, Phillip, Gurgenci, Taylan and Hardy, Janet (2024). Cannabinol oil or placebo in advanced cancer–disease progression and survival: a secondary analysis. BMJ Supportive and Palliative Care, 14 (2), 191-194. doi: 10.1136/spcare-2023-004746

Cannabinol oil or placebo in advanced cancer–disease progression and survival: a secondary analysis

2023

Journal Article

Quality of life beyond measure: Advanced cancer patients, wellbeing and medicinal cannabis

Smith, Alexandra, Olson, Rebecca E., da Costa, Nathalia Cordeiro, Cuerton, Maddison, Hardy, Janet and Good, Philip (2023). Quality of life beyond measure: Advanced cancer patients, wellbeing and medicinal cannabis. Sociology of Health and Illness, 45 (8), 1709-1729. doi: 10.1111/1467-9566.13684

Quality of life beyond measure: Advanced cancer patients, wellbeing and medicinal cannabis

2023

Journal Article

Exploring potential anti-inflammatory effects of medicinal cannabis

Gurgenci, Taylan, Kijanka, Gregor, Greer, Ristan, Huggett, Georgie, Good, Phillip, Moniruzzaman, Md and Hardy, Janet (2023). Exploring potential anti-inflammatory effects of medicinal cannabis. Supportive Care in Cancer, 31 (12) 629, 629. doi: 10.1007/s00520-023-08069-8

Exploring potential anti-inflammatory effects of medicinal cannabis

2023

Journal Article

Results from a type two hybrid‐effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway

Delaforce, Alana, Farmer, Shannon, Duff, Jed, Munday, Judy, Miller, Kristin, Glover, Lynne, Corney, Chris, Ansell, Gareth, Gutta, Naadir, Tuffaha, Haitham, Hardy, Janet and Hurst, Cameron (2023). Results from a type two hybrid‐effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway. Transfusion, 63 (4), 724-736. doi: 10.1111/trf.17287

Results from a type two hybrid‐effectiveness study to implement a preoperative anemia and iron deficiency screening, evaluation, and management pathway

Funding

Current funding

  • 2021 - 2026
    Medicinal Cannabis (MedCan 3) - randomised, multicentre, double blind, placebo-controlled trial to assess THC/CBD (1:20) to relieve symptom burden in patients with cancer
    NHMRC MRFF EPCDR Medicinal Cannabis
    Open grant

Past funding

  • 2018 - 2023
    Medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer
    NHMRC MRFF - Lifting Clinical Trials Registries Capacity
    Open grant
  • 2017 - 2020
    Talking about death: A study into palliative care communication
    Mater Misericordiae Ltd
    Open grant
  • 2010 - 2016
    A randomised controlled trial of aetiology based antiemetic guidelines for reducing nausea in advanced cancer patients (NHMRC Project Grant administered by QUT)
    Queensland University of Technology
    Open grant
  • 2010 - 2012
    n-of-1 trials of pilocarpine vs placebo for dry mouth in palliative care patients
    Cancer Council Queensland
    Open grant
  • 2009 - 2012
    Using n-of 1 trials to determine the effectiveness of paracetamol in advanced cancer patients on opioids
    NHMRC Palliative Care Research Program
    Open grant
  • 2008 - 2012
    Using single patient trials to determine the effectiveness of psychostimulants in end stage fatigue in cancer patients.
    NHMRC Palliative Care Research Program
    Open grant

Supervision

Availability

Honorary Professor Janet Hardy is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Honorary Professor Janet Hardy's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au